FFA
CRMD icon

First Foundation Advisors’s CorMedix CRMD Stock Holding History

First Foundation Advisors’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-16,640
Closed -$68.9K – 421
2023
Q1 		$68.9K Hold
16,640
– – ﹤0.01% 383
2022
Q4 		$70.2K Hold
16,640
– – ﹤0.01% 391
2022
Q3 		$47K Buy
+16,640
New +$69.2K ﹤0.01% 382

Other funds holding CRMD

Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $22.7B AUM 59.88% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

First Foundation Advisors's CRMD Position: Q2 2023 in Review

First Foundation Advisors sold out of CorMedix (CRMD) in Q2 2023, closing a stake of 16,640 shares — an estimated $68.9K sold.

First Foundation Advisors first reported a position in CRMD in Q3 2022 and held it in 3 quarters. The position peaked at $70.2K in Q4 2022. 86 funds tracked by Wall St. Rank hold CRMD as of Q2 2023.

  • First Foundation Advisors reported no remaining CorMedix position as of Q2 2023 after selling out during the quarter.
  • First Foundation Advisors sold 16,640 CorMedix shares in Q2 2023, an estimated $68.9K.
  • First Foundation Advisors first reported a position in CorMedix in Q3 2022 and held it in 3 quarters.
  • First Foundation Advisors's CorMedix position peaked at $70.2K in Q4 2022.
  • 86 funds tracked by Wall St. Rank held CorMedix as of Q2 2023.

Based on First Foundation Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.